NFX-21 (Nectid)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNFX-21 (Nectid)
Drug Alias NameRepurposed TricaprylinRepurposed TricaprilinNFX-21
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR modulators
TargetsBile acid receptor FXR
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesNectid
China Registration ClassN/A

Develop Information

Active CompaniesNectid
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A